Open Orphan - Early adopters signed for Genomic Health DataBANK
ORPH Mon, 25 Nov 2019, 08:45am GMT
Open Orphan was founded in 2017, with the goal of becoming Europe’s leading rare disease and orphan drug focused pharma services company by a management team with extensive industry and financial expertise.
Industry: Health Care
Contact: +353 (01) 6440007
Dublin 2, Ireland
Maurice Treacy, Chief Commercial Officer of Open Orphan, provides an update on the signing of five pharmaceutical and biotechnology companies as early adopters of its Genomic Health DataBANK platform. The platform is expected to be completed and rolled out in Q1 2020.